Trial Profile
The prevention of progression in CKD of medication adherence to AST-120 in patients with non-dialysis chronic kidney disease (CKD) and significance of measurement indoxyl sulfate as an indicator of medication adherence
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Apr 2019
Price :
$35
*
At a glance
- Drugs Charcoal (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- 03 Apr 2019 Status changed from recruiting to completed.
- 29 Aug 2016 New trial record